ARCHIVES

Endostatin Enters Phase II Trial For Neuroendocrine Tumors.

This article is from The Cancer Letter archive.

Vol. 27 No. 46 | December 14, 2001

Download PDF Visit The Full Archive

Related Articles

ASCO Sees Efforts Pay Off In Health Care Reform: Clinical Trials

October 1, 1993

Hyperthermia Offers Prospects For Major Treatment Advance, Investigators Says

March 11, 1977

In Brief: Appropriations Markup Delayed Until September; FCRC Recompetition Draws 94 Requests for RFP

July 31, 1981

Hyperthermia, Radiation Enhancement, New Drugs Offer More Therapy Advances, ASCO Members Hear

April 7, 1978

In Brief: San Antonia Cancer Institute Designated Comprehensive; Yeast DNA Described

May 3, 1996

House Medicare Reform Bill Takes A smaller Bite In Drug Reimbursement

June 20, 1997